Literature DB >> 28104817

Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.

Julia Hofhuis1, Kristina Bersch1, Ronja Büssenschütt1, Marzena Drzymalski1, David Liebetanz2, Viacheslav O Nikolaev3, Stefan Wagner4, Lars S Maier4, Jutta Gärtner1, Lars Klinge5, Sven Thoms5.   

Abstract

The multi-C2 domain protein dysferlin localizes to the plasma membrane and the T-tubule system in skeletal muscle; however, its physiological mode of action is unknown. Mutations in the DYSF gene lead to autosomal recessive limb-girdle muscular dystrophy type 2B and Miyoshi myopathy. Here, we show that dysferlin has membrane tubulating capacity and that it shapes the T-tubule system. Dysferlin tubulates liposomes, generates a T-tubule-like membrane system in non-muscle cells, and links the recruitment of phosphatidylinositol 4,5-bisphosphate to the biogenesis of the T-tubule system. Pathogenic mutant forms interfere with all of these functions, indicating that muscular wasting and dystrophy are caused by the dysferlin mutants' inability to form a functional T-tubule membrane system.
© 2017. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  5-bisphosphate; C2 domain protein; Dysferlin; Dysferlinopathy; Limb-girdle muscular dystrophy type 2B; Miyoshi myopathy; Muscular dystrophy; Phosphatidylinositol 4; T-tubule system

Mesh:

Substances:

Year:  2017        PMID: 28104817     DOI: 10.1242/jcs.198861

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

1.  Frequent DYSF rare variants/mutations in 152 Han Chinese samples with ovarian endometriosis.

Authors:  Li-Sha Peng; Zeng-Ming Li; Ge Chen; Fa-Ying Liu; Yong Luo; Jiu-Bai Guo; Guo-Dong Gao; Ying-Hui Deng; Li-Xian Xu; Jiang-Yan Zhou; Yang Zou
Journal:  Arch Gynecol Obstet       Date:  2021-05-13       Impact factor: 2.344

Review 2.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

3.  Loss of CASK Accelerates Heart Failure Development.

Authors:  Lars S Maier; Stefan Wagner; Julian Mustroph; Can M Sag; Felix Bähr; Anna-Lena Schmidtmann; Shamindra N Gupta; Alexander Dietz; M M Towhidul Islam; Charlotte Lücht; Bo Eric Beuthner; Steffen Pabel; Maria J Baier; Ali El-Armouche; Samuel Sossalla; Mark E Anderson; Julia Möllmann; Michael Lehrke; Nikolaus Marx; Peter J Mohler; Donald M Bers; Bernhard Unsöld; Tao He; Matthias Dewenter; Johannes Backs
Journal:  Circ Res       Date:  2021-02-17       Impact factor: 17.367

4.  Novel duplication mutation of the DYSF gene in a Pakistani family with Miyoshi Myopathy.

Authors:  Muhammad I Ullah; Arsalan Ahmad; Milena Zarkovic; Syed S Shah; Abdul Nasir; Saqib Mahmood; Wasim Ahmad; Christian A Hubner; Muhammad J Hassan
Journal:  Saudi Med J       Date:  2017-12       Impact factor: 1.484

5.  Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy.

Authors:  Rachael A Potter; Danielle A Griffin; Patricia C Sondergaard; Ryan W Johnson; Eric R Pozsgai; Kristin N Heller; Ellyn L Peterson; Kimmo K Lehtimäki; Hillarie P Windish; Plavi J Mittal; Douglas E Albrecht; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Hum Gene Ther       Date:  2017-07-13       Impact factor: 5.695

6.  Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes.

Authors:  Julian Mustroph; Olivia Wagemann; Charlotte M Lücht; Maximilian Trum; Karin P Hammer; Can Martin Sag; Simon Lebek; Daniel Tarnowski; Jörg Reinders; Filippo Perbellini; Cesare Terracciano; Christof Schmid; Simon Schopka; Michael Hilker; York Zausig; Steffen Pabel; Samuel T Sossalla; Frank Schweda; Lars S Maier; Stefan Wagner
Journal:  ESC Heart Fail       Date:  2018-08

Review 7.  The expanding spectrum of neurological disorders of phosphoinositide metabolism.

Authors:  Jonathan R Volpatti; Almundher Al-Maawali; Lindsay Smith; Aqeela Al-Hashim; Julie A Brill; James J Dowling
Journal:  Dis Model Mech       Date:  2019-08-13       Impact factor: 5.758

8.  Diltiazem improves contractile properties of skeletal muscle in dysferlin-deficient BLAJ mice, but does not reduce contraction-induced muscle damage.

Authors:  Morium Begam; Alyssa F Collier; Amber L Mueller; Renuka Roche; Sujay S Galen; Joseph A Roche
Journal:  Physiol Rep       Date:  2018-06

9.  Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.

Authors:  Elinam Gayi; Laurence A Neff; Xènia Massana Muñoz; Hesham M Ismail; Marta Sierra; Thomas Mercier; Laurent A Décosterd; Jocelyn Laporte; Belinda S Cowling; Olivier M Dorchies; Leonardo Scapozza
Journal:  Nat Commun       Date:  2018-11-19       Impact factor: 14.919

10.  Cardiomyocyte damage control in heart failure and the role of the sarcolemma.

Authors:  Ashraf Kitmitto; Florence Baudoin; Elizabeth J Cartwright
Journal:  J Muscle Res Cell Motil       Date:  2019-09-13       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.